The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
University of Texas researchers have recently identified the mechanism controlling the body's fight against Hepatitis C. This groundbreaking research is already being utilized to design new treatments allowing the body to clear this and other viruses.
Continue reading »Anemia is a common side effect caused by the drugs used in Hepatitis C combination therapy. For affected individuals, researchers found that a red blood cell-boosting drug can increase tolerance for receiving full-strength Hepatitis C treatment.
Continue reading »Encouraging results were just announced regarding the battle on liver cancer, a devastating illness that may follow Hepatitis C infection. Recently demonstrated to decrease liver tumor recurrence by 76 percent, Progen Industries' PI-88 will progress to Phase III clinical trials for liver cancer treatment.
Continue reading »A recent study has shown how HIV diminishes the immune system's ability to respond to Hepatitis C. Researchers from Massachusetts General Hospital indicate that co-infected individuals should begin anti-retroviral treatment earlier than those only infected with Hepatitis C.
Continue reading »Pegylated interferon and ribavirin therapy non-responders are the focus of a Phase 4 study evaluating the safety and efficacy of Infergen® (consensus interferon) in combination with ribavirin.
Continue reading »A Brazilian case study report indicates that by adding thalidomide to standard combination therapy, six HCV-positive, prior non-responders experienced total remission of their chronic Hepatitis C. Known to cause severe congenital abnormalities, thalidomide's safety and efficacy must be investigated in future Hepatitis C trials before being considered as a viable treatment.
Continue reading »DNA vaccines are the next wave of hope in disease prevention. Scheduled to make its clinical trial debut in early 2007, Inovio's proprietary electroporation DNA delivery system is designed to activate a T-cell response capable of clearing HCV.
Continue reading »An Australian clinical trial is testing a novel strategy for battling Hepatitis C. Physicians are starting to treat Hepatitis C patients with oglufanide, a drug capable of regulating the body's immune response.
Continue reading »Spanish researchers recently investigated the growing trend of basing ribavirin dosages on weight for those co-infected with HIV and Hepatitis C. Their results demonstrate substantial benefit to weight-dosing, and confirm the need for this individualized treatment approach.
Continue reading »Separating personal items used by a person with Hepatitis C from other household members to prevent transmission may seem overly cautious. However, a recently published study confirms the risk of spreading Hepatitis C by sharing a toothbrush.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
